Trial Profile
A multicentre, observational trial to characterise incidence of neutropenia in relapse/refractory patients of multiple myeloma treated with lenalidomide and dexamethasone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2017
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions
- 14 Dec 2015 New trial record